Asensus Surgical, Inc. (ASXC), a provider of digital solutions for surgical processes, announced on Friday that it has finalized a merger agreement with KARL STORZ Endoscopy-America, Inc., a division of the medical technology company KARL STORZ SE & Co. KG.
ASXC shares saw a significant increase of 42.20%, trading at $0.333 on the New York Stock Exchange. According to the agreement, KARL STORZ will acquire Asensus Surgical for $0.35 per share in cash.
This acquisition price represents a premium of approximately 67% over Asensus's closing price on the NYSE as of April 2, and about 52% higher than the closing price from the last trading day prior to the merger announcement.
Upon the expected completion of the transaction in the third quarter, Asensus Surgical will operate as a subsidiary of KARL STORZ Endoscopy-America and will cease to be publicly listed.
